Epana Bio is a startup based in the United States.
Epana Bio is a biotechnology company developing precision therapies for autoimmune diseases by targeting the cellular origin of autoimmunity. It uses genomics and AI to design patient-tailored treatments intended to reset the immune system rather than just manage symptoms.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.